Receptor programowanej śmierci 1 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptor programowanej śmierci 1" in Polish language version.

refsWebsite
Global rank Polish rank
5th place
2nd place
2nd place
6th place
4th place
7th place
149th place
235th place
857th place
738th place
low place
low place
234th place
204th place

doi.org (Global: 2nd place; Polish: 6th place)

dx.doi.org

jimmunol.org (Global: low place; Polish: low place)

nature.com (Global: 234th place; Polish: 204th place)

nih.gov (Global: 4th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • Fen Huang, Bo Wang, Jiangzheng Zeng, Shenggang Sang, Junhua Lei, MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells, „Oncology Letters”, 15 (4), 2018, s. 4797–4804, DOI10.3892/ol.2018.7951, ISSN 1792-1074, PMID29552119, PMCIDPMC5840577.
  • T. Shinohara, M. Taniwaki, Y. Ishida, M. Kawaichi, T. Honjo, Structure and chromosomal localization of the human PD-1 gene (PDCD1), „Genomics”, 23 (3), 1994, s. 704–706, DOI10.1006/geno.1994.1562, ISSN 0888-7543, PMID7851902 [dostęp 2018-04-19].
  • Y. Ishida, Y. Agata, K. Shibahara, T. Honjo, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, „The EMBO journal”, 11 (11), 1992, s. 3887–3895, ISSN 0261-4189, PMID1396582, PMCIDPMC556898 [dostęp 2018-04-19].
  • Enfu Hui, Jeanne Cheung, Jing Zhu, Xiaolei Su, Marcus J. Taylor, T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition, „Science”, 355 (6332), 2017, s. 1428–1433, DOI10.1126/science.aaf1292, ISSN 0036-8075, PMID28280247 (ang.).
  • Pierre Serra, Arthur Petat, Jean-Michel Maury, Françoise Thivolet-Bejui, Lara Chalabreysse, Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma, „Lung Cancer”, 118, 2018, s. 62–68, DOI10.1016/j.lungcan.2018.02.005, ISSN 1872-8332, PMID29572005 [dostęp 2018-04-19].
  • Audrey Monneur, Anthony Gonçalves, François Bertucci, [PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer], „Bulletin Du Cancer”, 105 (3), 2018, s. 263–274, DOI10.1016/j.bulcan.2017.11.012, ISSN 1769-6917, PMID29455872 [dostęp 2018-04-19].
  • Peter T. Sage, Frank A. Schildberg, Raymond A. Sobel, Vijay K. Kuchroo, Gordon J. Freeman, Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function, „The Journal of Immunology”, 200 (8), 2018, s. 2592–2602, DOI10.4049/jimmunol.1701231, ISSN 0022-1767, PMID29531164 (ang.).
  • Poonam Mathur, Benjamin Emmanuel, Michael Sneller, Xiaozhen Zhang, Bhawna Poonia, Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis, „Journal of Medical Virology”, 90 (5), 2018, s. 936–941, DOI10.1002/jmv.25002, ISSN 1096-9071, PMID29236302, PMCIDPMC5849501 [dostęp 2018-04-19].
  • Yuan-Mei Che, Yi Zhang, Ming Li, Xiao-Peng Li, Lun-Li Zhang, In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis, „Journal of Cellular Biochemistry”, 119 (4), 2018, s. 3044–3057, DOI10.1002/jcb.26432, ISSN 1097-4644, PMID29058791 [dostęp 2018-04-19].

sciencedirect.com (Global: 149th place; Polish: 235th place)

sciencemag.org (Global: 857th place; Polish: 738th place)

science.sciencemag.org

worldcat.org (Global: 5th place; Polish: 2nd place)